Physician profile
Terry R Bowers
NPI 1972586758
$254,822.09
in general payments reported to CMS, 2019-2025
29 companies · $35K in 2025
The $35K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $7,173 · 2021: $11K · 2022: $83K · 2023: $57K · 2024: $34K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $100K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $4,552 · Travel and Lodging: $3,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $99,811.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,400.00 |
| Food and Beverage | $4,552.08 |
| Travel and Lodging | $3,368.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $95,520.80 | 2019-2025 | Zoom 88-T Large Distal Platform, Symphony Catheter, Prodigy Catheter |
| Janssen Pharmaceuticals, INC | $67,299.95 | 2019-2024 | Xarelto |
| Truvic Medical, INC. | $58,253.19 | 2022 | |
| Boston Scientific Corporation | $10,629.55 | 2019-2025 | General - Therapies, Eluvia, Ekosonic |
| Pfizer INC. | $9,287.66 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $7,641.27 | 2019-2022 | |
| Inari Medical, INC. | $3,083.59 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $493.41 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $404.07 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $340.46 | 2020-2025 | Jardiance |
| Angiodynamics, INC. | $279.48 | 2021-2023 | Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $245.68 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $216.68 | 2019 | |
| Abbott Laboratories | $175.93 | 2021-2025 | Xience Alpine |
| Medtronic Vascular, INC. | $160.95 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $141.88 | 2024 | Indigo System |
| Janssen Scientific Affairs, LLC | $124.84 | 2019 | |
| Amarin Pharma, INC. | $114.43 | 2019-2021 | |
| Medtronic, INC. | $70.54 | 2024 | V-Loc 180 |
| Astrazeneca Pharmaceuticals Lp | $60.70 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $59.64 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.96 | 2019-2025 | |
| Gilead Sciences, INC. | $43.72 | 2019 | |
| Bard Peripheral Vascular, INC. | $27.03 | 2019 | |
| Merck Sharp & Dohme LLC | $24.13 | 2021 | |
| Esperion Therapeutics, INC. | $22.81 | 2021 | |
| Bardy Diagnostics, INC. | $17.50 | 2020 | |
| Shockwave Medical, INC | $16.61 | 2021 | |
| Preventice Services, LLC | $15.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$253,422.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.